PSCHvsBBCETF Comparison
VS
Invesco S&P SmallCap Health Care ETF (PSCH) belongs to the US Health Care segment. Virtus LifeSci Biotech Clinical Trials ETF (BBC) is part of the Tomorrow's Treatments segment. Both ETFs have the same top 1 sector exposures: Healthcare. PSCH is less expensive with a Total Expense Ratio (TER) of 0.29%, versus 0.65% for BBC. PSCH is up 22.45% year-to-date (YTD) with -$1M in YTD flows. BBC performs worse with 6.51% YTD performance, and +$5M in YTD flows. Run a side-by-side ETF comparison of PSCH and BBC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PSCH vs BBC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/23/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PSCH BBC | +2.58%-11.86% | +1.83%-18.16% | +22.45%+6.51% | +26.77%+38.62% | +52.89%+147.07% | -9.76%-4.52% |
| Flows | PSCH BBC | -$13M- | +$10M- | -$1M+$5M | -$1M+$12M | -$102M+$16M | -$210M+$8M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PSCH BBC | +16.86%+35.88% | +19.43%+36.96% | +21.81%+37.65% | +22.92%+39.97% |
| Max drawdown | PSCH BBC | -8.61%-29.70% | -15.36%-29.70% | -22.80%-54.25% | -45.76%-70.04% |
| Max drawdown duration | PSCH BBC | 65d65d | 168d65d | 488d340d | 1810d1625d |
Trading data
PSCH | BBC | |
Last sale 10/23/2026 at 1:30 PM | $54.00 | $41.22 |
| Previous close 10/22/2026 | $54.29 | $42.13 |
| Consolidated volume 10/22/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
PSCH | BBC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/23/2026 at 1:30 PM
Live
Closed
PSCH | BBC | |
|---|---|---|
| Last price | $54.00 | $41.22 |
| 1D performance | -0.53% | -2.16% |
| AuM | $173.83 M | $39.14 M |
| E/R | 0.29% | 0.65% |
Characteristics
PSCH | BBC | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Invesco | VIRTUS Investment Partners |
| Benchmark | S&P SmallCap 600 Capped Health Care Index | LifeSci Biotechnology Clinical Trials Index |
| N° of holdings | 69 | 127 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 7, 2010 | December 16, 2014 |
| ESG | No | No |
Exposure
Countries
PSCH
USA
94.93%
Other
5.07%
BBC
USA
87.24%
Other
12.76%
Sectors
PSCH
Healthcare
100%
Other
0%
BBC
Healthcare
96.27%
Other
3.73%
Advertisement
Diversification
PSCH
Total weight of top 15 holdings out of 15
48.62%
BBC
Total weight of top 15 holdings out of 15
17.14%
Top 15 holdings
Data as of August 31, 2026
PSCH
Corcept Therapeutics, Inc.
5.61%
Glaukos Corp.
5.37%
Protagonist Therapeutics, Inc.
4.54%
Alkermes Plc
4.09%
TG Therapeutics, Inc.
3.69%
Teleflex, Inc.
3.06%
PTC Therapeutics, Inc.
2.99%
Ligand Pharmaceuticals, Inc.
2.87%
Merit Medical Systems, Inc.
2.68%
RadNet, Inc.
2.68%
Liquidia Corp.
2.47%
ICU Medical, Inc.
2.20%
Indivior Pharmaceuticals, Inc.
2.16%
Integer Holdings Corp.
2.14%
Concentra Group Holdings Parent, Inc.
2.07%
BBC
Amylyx Pharmaceuticals, Inc.
1.50%
First Tracks Biotherapeutics, Inc.
1.48%
AbCellera Biologics, Inc.
1.38%
Xencor, Inc.
1.36%
Monopar Therapeutics, Inc.
1.12%
MBX Biosciences, Inc.
1.11%
uniQure NV
1.09%
Replimune Group, Inc.
1.06%
4D Molecular Therapeutics, Inc.
1.04%
SELLAS Life Sciences Group, Inc.
1.04%
Alto Neuroscience, Inc.
1.00%
LB Pharmaceuticals, Inc.
1.00%
Oric Pharmaceuticals, Inc.
0.99%
Zenas BioPharma, Inc.
0.98%
Cullinan Therapeutics, Inc.
0.98%
Frequently asked questions about PSCH and BBC
How have the PSCH and BBC ETFs performed in 2026?
As of October 23, 2026, PSCH is up 22.45% year-to-date (YTD), while BBC has returned 6.51%. That puts PSCH better performer ahead so far this year.
Which ETF is attracting more investor money: PSCH or BBC?
Year-to-date, the PSCH ETF saw -$1M in flows, compared to +$5M for BBC.
Which ETF is more volatile: PSCH or BBC?
Over the past year, PSCH had a volatility of 19.43%, while BBC experienced 36.96%.
Which ETF is bigger: PSCH or BBC?
As of October 23, 2026, PSCH holds $173.83 M in assets under management (AUM), while BBC manages $39.14 M.
What sectors do the PSCH and BBC ETFs invest in?
PSCH leans toward sectors like Healthcare. Meanwhile, BBC focuses on Healthcare.
What are the top holdings of the PSCH ETF and BBC ETF?
PSCH top holdings include Corcept Therapeutics, Inc., Glaukos Corp. and Protagonist Therapeutics, Inc.. BBC holds in its top three: Amylyx Pharmaceuticals, Inc., First Tracks Biotherapeutics, Inc. and AbCellera Biologics, Inc..
Which ETF is more diversified: PSCH or BBC?
PSCH holds 69 securities with 48.62% of its assets in the top 15. BBC has 127 securities and a top 15 weight of 17.14%.
Advertisement
Latest news about PSCH & BBC
Advertisement
